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Endoscopy has revolutionized the management ofdigestive diseases in general
and ulcer disease in particular. It allows the physician to view the pathologic
process directly, and with biopsy and cytology techniques, to obtain histologi-
cal samples. Endoscopy helped to usher in the field ofminimally invasive ther-
apy and endoscopic treatment ofbleeding ulcers and is now a standard form of
treatment. This overview is divided into three parts: first, the current diagnostic
and therapeutic endoscopic management of ulcer disease will be addressed;
second, some of the current work that should have future applications in the
same area will be discussed. Finally, some conceptual ideals that look further
beyond future applications will be addressed.
CURRENT APPLICATIONS
Diagnostic endoscopy
Esophagogastroduodenoscopy (EGD)b or upper endoscopy is used with increasing
frequency either as a replacement for upper GI radiographs (upper GI series), as a com-
plementary study for the evaluation of "ulcer" symptoms or for upper GI bleeding. In
addition to the fact that EGD is more sensitive than upper GI X-rays, it also allows the
physician to sample tissue (for example, biopsies, cytology or Helicobacterpylori). It is
also common to use EGD for follow-up evaluation ofgastric ulcers.
Therapeutic endoscopy
There currently is little application ofendoscopy to the management ofprimary ulcer
disease; rather, endoscopy has mainly been used for the management of complications of
ulcer disease (bleeding, obstruction or perforation). There are some proposed endoscopic
managements of the primary disease, and that will be addressed with future applications.
Most commonly, endoscopy is used for the diagnosis and therapy of bleeding ulcers. The
endoscopic options are shown in Table 1 [1].
At an NIH Consensus Conference in 1989, it was concluded that endoscopic therapy
was beneficial in the management of bleeding ulcers [2]. The panelists concluded that
multipolar electrocoagulation, heater probe, Nd:YAG laser and injection therapy all might
be of benefit. They did not feel that topical therapies, Argon laser or monopolar electro-
cautery should be utilized.
Evidence that the multipolar electrocoagulation (MPEC) is ofbenefit comes from two
studies. The first study included 44 patients with evidence of upper GI bleeding. MPEC
treatment resulted in significant improved hemostasis, reduction in transfusion require-
ments, decreased need for urgent surgery and shorterperiods ofhospitalization [3].
aTo whom all correspondence should be addressed: Division of Gastroenterology, Georgetown
University Hospital, 3800 Reservoir Road, NW, Washington, D.C. 20007. Tel: (202) 678-8741;
Fax: (202) 784-3957.
bAbbreviations used: EGD, esophagogastroduodenoscopy; MPEC, multipolar electrocoagulation;
EUS, endoscopic ultrasonography; LIFS, laser induced fluorescent spectroscopy.
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Table 1. Endoscopic treatment for gastrointestinal bleeding
A. Topical:
1. Tissue adhesives
2. Collagen
3. Clotting Factors
4. Ferromagnetic tamponade
B. Injection:
1. Sclerosing agents
2. Vasoconstricting agents
C. Mechanical:
1. Clips
2. Balloons
D. Thermal:
1. Electrocoagulation
2. Heat probe
3. Laser
4. Cryotherapy
E. Combination
Whereas the first study had evaluated MPEC for the treatment ofactive bleeding and
lesions, the second study looked at nonbleeding visible vessels in ulcers. MPEC treatment
reduced rebleeding, and the need for urgent surgery, transfusion requirements, length of
hospitalization and hospital costs were also lowered in the treated group [4].
Heater probes have also been useful for ulcer hemostasis [5]. Randomized trials have
shown significant benefit. In a study from Scotland, patients with active bleeding or visi-
ble vessel were randomized to medical/surgical treatment or heater probe medical treat-
ment. The latter reduced rebleeding rates [6].
One hundred and thirty-seven patients with severe upper GI bleeding were prospec-
tively evaluated in a study from China [7]. The patients treated with heater probe had bet-
ter outcomes than those treated with alcohol injection or those in a medical treatment
group. A study from UCLA compared medical treatment, MPEC and heater probe treat-
ment. The latter two groups had reduced bleeding rates, transfusion requirements and the
need for urgent surgery [8].
Although Nd:YAG laser is not commonly employed for endoscopic management of
GI bleeding, good efficacy has been reported with that form of treatment. Twelve ran-
domized, controlled trials compared laser treatment with other forms of therapy. In the
large majority oftrials, there has been significant benefit from laser therapy [9-20].
The NIH Consensus Conference rated injection therapy as very promising, but at the
time of the Conference in 1989, only a few studies had been performed. Subsequent to
that meeting, injection therapy has become a procedure that is commonly employed.
Panes and colleagues [37] compared injection therapy with medical treatment in a group
of patients, and there was a significant reduction in rebleeding rates, transfusion require-
ments and need for urgent surgery. Chung and associates [24] randomized patients with
actively bleeding ulcers into injection therapy or medical therapy. Transfusion require-
ments and need for urgent surgery were reduced in the injection group [21]. Several other
controlled trials yielded similarly favorable results [22-25].
The choice of endoscopic therapy is largely dictated by the endoscopist's personal
preference. There is a consensus that endoscopic therapy is effective and safe for the
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Table 2. Prognostic implication ofappearance ofulcer at the time ofendoscopy
Risk ofcontinued Incidence of
Endoscopic findings bleeding (%) findings (%)
Spurting artery 85% 8%
Visible vessel (nonbleeding) 51% 26%
Overlying clot 41% 18%
Central red/black spot 5% 12%
Clean base 0% 36%
management of bleeding peptic ulcers. The studies quoted above attest not only to the
efficacy ofendoscopic therapy but also to its safety. The most serious complication, per-
foration, occurs in one percent or less oftreatments.
There has been a debate about which ulcers are most amenable to treatment. The
endoscopic appearance of the ulcer affects that decision. Table 2 shows the prognostic
implications ofthe endoscopic appearance ofthe ulcer at the time ofendoscopy [26].
It can be appreciated that the endoscopic finding is a relevant factor in determining
whether or not to institute endoscopic therapy. There is a general consensus that an ulcer
with a clean base should not be treated. There is divergence of opinion as to whether or
not a nonbleeding visible vessel should be treated, since approximately one half rebleed
and one halfdo not.
There are some limitations to endoscopic therapy. Some limitations exist because the
situation is clinically difficult. If the patient is hemodynamically unstable or cannot be
sedated, these present clinically difficult problems. Other situations are technically diffi-
cult. In some cases, the problem is access, either because there is overlying blood or the
bleeding point is at a spot where endoscopic access is difficult (e.g., just inside the bulb).
In other cases, the situation is technically difficult because our current therapies are inef-
fective. Often fimes, bleeding in the posterior duodenum is from a branch of the gastro-
duodenal artery, and if the size of the vessel is greater than 1 mm, endoscopic therapies
may be ineffective. Finally, sometimes the problem is conceptually difficult. What should
be done in the case ofrebleeding or ifa bleeding source is not obvious after evaluation?
Current research is addressing the limitations of endoscopic therapy with the hopes
that solutions to these problems might emerge. Some examples of potential solutions are
as follows. Use of an endoscopic Doppler might allow better definition offlow below the
surface of a nonbleeding visible vessel. Kohler and Riemann demonstrated the benefit of
endoscopic Doppler application [27]. An approach to dealing with the vessel that is "too
large" involves the use ofendoscopic clips or sutures.
Endoscopic therapy has also been used for gastric outlet obstruction. Benjamin et al.
described the use ofendoscopic balloon dilation forpyloric stenosis secondary to scarring
from previous ulcer disease [28]. A series of balloons that can be used endoscopically
now exist for this application.
The conventional wisdom is that surgery is and should be the management of a per-
forated ulcer. Traditionally, that surgery has been via an open laparotomy. However, there
are some reports ofeither laparoscopic orendoscopic sewing to close offa perforation.
FUTURE APPLICATIONS
It is interesting to speculate how some of the newer diagnostic technologies that are
being applied to gastrointestinal endoscopy might be utilized for the management ofulcer
disease:
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Diagnostic applications
With the advent of electronic endoscopes, a digitized image was created [29]. With
an electronic endoscope as opposed to a fiberoptic endoscope, the creation of a digital
image allows it to be combined with computer technology. Yamaguchi et al. utilized this
principle in determining the three-dimensional gastric ulcer size. [30]. Tsuji et al. used
digitized endoscopy for the analysis of mucosal blood hemoglobin distribution [31].
Endoscopic ultrasonography (EUS) is employed in the evaluation of digestive dis-
eases. It is commonly used to stage gastrointestinal malignancies. However, it would be
possible to use EUS to help distinguish between benign and malignant ulcers or to better
understand ulcer healing. Laser induced fluorescent spectroscopy (LIFS) is another tech-
nology that might be applied to better understand gastric physiology. Its primary applica-
tion in the digestive tract to date has been to characterize benign versus malignant poly-
poid disease. However, it would also be possible to use similar principles to study mucos-
al hemodynamics [32].
Therapeutic applications
Many pioneers of gastrointestinal endoscopy have realized that if the endoscope can
deliver the investigator to the pathologic process then therapy should be possible. Joffe
and Sankar describe the endoscopic vagotomy and antrectomy [33]. Using contact
Nd:YAG laser therapy, they demonstrated, in a canine model, that if the G cells of the
antrum were destroyed with the laser and the pathway to the vagal nerves interrupted then
acid secretion could be reduced. This procedure was carried out completely via
endoscopy.
Another advance in the area ofminimally invasive therapy is the field ofendo-organ
surgery. With this technique, multiple access ports are created between the abdominal
wall of the stomach using modified gastrostomy ports [34]. This would allow for the
introduction of instruments into the stomach (and esophagus and small bowel) for man-
agement of GI conditions. Endo-organ fundoplications have been carried out as well as
techniques for managing major gastrointestinal hemorrhage.
With the appreciation that H. pylori is likely involved in the pathogenesis of some
ulcers, some investigators have speculated about the endoscopic eradication ofH. pylori.
Others have raised the possibility of other endoscopic approaches which may be benefi-
cial in ulcer healing. These have included photostimulation, the endoscopic delivery of
medical therapy, injection treatment ofa healing factor or even molecular modulation.
BEYOND FUTURE APPLICATIONS
The parallel in convergent technologies that exist both within medicine and other
areas have led to incredible speculations. Application of the work that is being done in
the areas of computer science, defense systems, space technology and entertainment can
all have applications for medicine in general and the management of ulcer disease in spe-
cific. The applications of robotics, telepresence and virtual reality may all have a role in
the management of ulcer disease [35]. Conceivably, a robotic endoscope could be swal-
lowed by the patient and guided to the site of the bleeding ulcer where robotic therapy
could be delivered. By telepresence technology, the surgeon or endoscopist in one city
might operate on a patient with an ulcer residing in another city. And finally in the appli-
cation ofvirtual reality technology, the treating physician may "fly" into the cell and alter
the sodium-potassium-ATPase pump which regulates acid secretion.
It can be seen that endoscopy is very important in the management of ulcer disease.
The ulcer can be precisely localized and characterized. In situations where bleeding
occurs, a wide range of endoscopic therapies are available, many of which have been
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proven to be safe and effective. The potential to develop even more helpful diagnostic
and therapeutic measures may be possible with several of the new technologies that are
being applied to that task.
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